IMARC Group provides an analysis of the key trends in each segment of the global L-carnitine market report, along with forecasts at the global, regional, and country levels from 2026-2034
Not everyone should try intermittent fasting
There was no difference when GLP-1s were compared with a third class of diabetes medications known as sodium-glucose cotransporter 2 inhibitors (SGLT2i)
Cagrilintide is a long-acting analog of amylin , a hormone secreted by the pancreas alongside insulin
When you are already dealing with the gastrointestinal effects of a GLP-1 medication, choosing the right form matters enormously
while 7 of the 12 patients reported subjective pain relief exceeding six months, the complete absence of a placebo control group or standardized pain-scale methodology severely limits the scientific validity and reproducibility of the findings